This inventor holds 1 USPTO granted patent. Top assignee: Glaxosmithkline Biologicals Sa. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Lucile Warter: Innovator in Chikungunya Virus Research
Introduction
Lucile Warter is a notable inventor based in Rixensart, Belgium. She has made significant contributions to the field of virology, particularly in the development of vaccines for Chikungunya virus infections. Her work is crucial in addressing the health challenges posed by this virus.
Latest Patents
Lucile Warter holds a patent for "Chikungunya virus antigen constructs." This invention provides adenoviral vectors that comprise transgenes encoding Chikungunya virus antigens. The vectors can be utilized to produce vaccines aimed at the prophylaxis, amelioration, and treatment of diseases caused by Chikungunya virus infections. She has 1 patent to her name.
Career Highlights
Lucile Warter is associated with GlaxoSmithKline Biologicals SA, where she continues her research and development efforts. Her work at this leading pharmaceutical company underscores her commitment to advancing public health through innovative solutions.
Collaborations
Lucile collaborates with esteemed colleagues, including Kate Luisi and Martine Harvey. These partnerships enhance the research and development process, fostering a collaborative environment that drives innovation.
Conclusion
Lucile Warter's contributions to Chikungunya virus research exemplify her dedication to improving global health. Her innovative work in vaccine development is vital in combating viral infections and showcases the importance of scientific research in addressing public health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile